OmniAb (OABIW) Competitors $0.24 +0.06 (+31.67%) As of 08/8/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock OABIW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, and CLNNWShould you be buying OmniAb stock or one of its competitors? The main competitors of OmniAb include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), and Clene (CLNNW). These companies are all part of the "biotechnology" industry. OmniAb vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene OmniAb (NASDAQ:OABIW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations, media sentiment and institutional ownership. Is OABIW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets OmniAbN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media refer more to OABIW or ATNFW? In the previous week, OmniAb's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment OmniAb Neutral 180 Life Sciences Neutral Which has preferable earnings and valuation, OABIW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmniAb$23.03MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryOmniAb beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get OmniAb News Delivered to You Automatically Sign up to receive the latest news and ratings for OABIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OABIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OABIW vs. The Competition Export to ExcelMetricOmniAbBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$134.73M$5.44B$9.61BDividend YieldN/A3.74%4.61%4.14%P/E RatioN/A3.7929.7624.84Price / SalesN/A4,344.35449.1298.65Price / CashN/A13.1936.4258.36Price / BookN/A38.648.185.64Net IncomeN/A-$90.30M$3.26B$265.68M7 Day Performance54.17%1.98%6.88%4.95%1 Month Performance-7.50%3.92%1.00%0.83%1 Year Performance-35.07%193.72%28.85%22.18% OmniAb Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OABIWOmniAbN/A$0.26+43.9%N/A-35.1%$0.00$23.03M0.00106Gap UpATNFW180 Life SciencesN/A$0.01-13.6%N/A+22.0%$0.00N/A0.007Gap DownHigh Trading VolumeSXTPW60 Degrees PharmaceuticalsN/A$0.04-40.6%N/A+86.0%$0.00$665.45K0.002Positive NewsGap DownDRTSWAlpha Tau MedicalN/A$0.23-3.8%N/A+11.3%$0.00N/A0.0080Gap UpAPLMWApollomicsN/A$0.03+8.6%N/A+130.0%$0.00N/A0.0059Positive NewsGap DownBCTXWBriaCell TherapeuticsN/A$0.04-19.6%N/A-83.7%$0.00N/A0.008Positive NewsGap DownCDIOWCardio DiagnosticsN/A$0.01-1.4%N/A-71.0%$0.00$19.90K0.007Positive NewsGap DownCELUWCelularityN/A$0.06+20.0%N/A+172.1%$0.00$54.22M0.00220Positive NewsGap DownCEROWCERo TherapeuticsN/A$0.02+11.2%N/A-53.3%$0.00N/A0.008Positive NewsShort Interest ↑CINGWCingulateN/A$0.12-11.5%N/A+697.8%$0.00N/A0.0020Positive NewsGap DownCLNNWCleneN/A$0.04+31.7%N/AN/A$0.00$350K0.00100Positive NewsGap Up Related Companies and Tools Related Companies 180 Life Sciences Competitors 60 Degrees Pharmaceuticals Competitors Alpha Tau Medical Competitors Apollomics Competitors BriaCell Therapeutics Competitors Cardio Diagnostics Competitors Celularity Competitors CERo Therapeutics Competitors Cingulate Competitors Clene Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OABIW) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OmniAb, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OmniAb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
